Roberts Derek J, Nagpal Sudhir K, Stelfox Henry T, Brandys Tim, Corrales-Medina Vicente, Dubois Luc, McIsaac Daniel I
Department of Surgery, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
The O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada.
JMIR Res Protoc. 2021 Sep 16;10(9):e28759. doi: 10.2196/28759.
Surgical site infections (SSIs) are common, costly, and associated with increased morbidity and potential mortality after lower limb revascularization surgery (ie, arterial bypass, endarterectomy, and patch angioplasty). Identifying evidence-informed risk factors for SSI in patients undergoing these surgeries is therefore important.
The aim of this study is to conduct a systematic review and meta-analysis of prognostic studies to identify, synthesize, and determine the certainty in the cumulative evidence associated with reported risk factors for early and delayed SSI after lower limb revascularization surgery in adults with peripheral artery disease.
We will search MEDLINE, Embase, the seven databases in Evidence-Based Medicine Reviews, review articles identified during the search, and included article bibliographies. We will include studies of adults (aged ≥18 years) with peripheral artery disease that report odds ratios, risk ratios, or hazard ratios adjusted for the presence of other risk factors or confounding variables and relating the potential risk factor of interest to the development of SSI after lower limb revascularization surgery. We will exclude studies that did not adjust for confounding, exclusively examined certain high-risk patient cohorts, or included >20% of patients who underwent surgery for indications other than peripheral artery disease. The primary outcomes will be early (in-hospital or ≤30 days) SSI and Szilagyi grade I (cellulitis involving the wound), grade II (infection involving subcutaneous tissue), and grade III (infection involving the vascular graft) SSI. Two investigators will independently extract data and evaluate the study risk of bias using the Quality in Prognosis Studies tool. Adjusted risk factor estimates with similar definitions will be pooled using DerSimonian and Laird random-effects models. Heterogeneity will be explored using stratified meta-analyses and meta-regression. Finally, we will use the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to determine certainty in the estimates of association between reported risk factors and the development of SSI.
The protocol was registered in PROSPERO (International Prospective Register of Systematic Reviews). We will execute the peer-reviewed search strategy on June 30, 2021, and then complete the review of titles and abstracts and full-text articles by July 30, 2021, and September 15, 2021, respectively. We will complete the full-text study data extraction and risk of bias assessment by November 15, 2021. We anticipate that we will be able to submit the manuscript for peer review by January 30, 2022.
This study will identify, synthesize, and determine the certainty in the cumulative evidence associated with risk factors for early and delayed SSI after lower limb revascularization surgery in patients with peripheral artery disease. The results will be used to inform practice, clinical practice statements and guidelines, and subsequent research.
PROSPERO International Prospective Register of Systematic Reviews CRD42021242557; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=242557.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/28759.
手术部位感染(SSIs)很常见,成本高昂,并且与下肢血管重建手术(即动脉搭桥术、动脉内膜切除术和补片血管成形术)后发病率增加和潜在死亡率相关。因此,识别接受这些手术患者发生SSI的循证风险因素很重要。
本研究的目的是对预后研究进行系统评价和荟萃分析,以识别、综合并确定与外周动脉疾病成年患者下肢血管重建手术后早期和延迟SSI报告的风险因素相关的累积证据的确定性。
我们将检索MEDLINE、Embase、循证医学综述中的七个数据库、检索过程中识别的综述文章以及纳入文章的参考文献。我们将纳入外周动脉疾病成年患者(年龄≥18岁)的研究,这些研究报告了针对其他风险因素或混杂变量的存在进行调整的优势比、风险比或风险率,并将感兴趣的潜在风险因素与下肢血管重建手术后SSI的发生相关联。我们将排除未对混杂因素进行调整、专门研究某些高风险患者队列或纳入超过20%因外周动脉疾病以外的适应症接受手术患者的研究。主要结局将是早期(住院期间或≤30天)SSI以及希拉吉I级(涉及伤口的蜂窝织炎)、II级(涉及皮下组织的感染)和III级(涉及血管移植物的感染)SSI。两名研究人员将独立提取数据,并使用预后研究质量工具评估研究的偏倚风险。将使用DerSimonian和Laird随机效应模型汇总具有相似定义的调整后风险因素估计值。将使用分层荟萃分析和荟萃回归探索异质性。最后,我们将使用推荐分级、评估、制定和评价(GRADE)方法来确定报告的风险因素与SSI发生之间关联估计值的确定性。
该方案已在国际前瞻性系统评价注册库(PROSPERO)中注册。我们将于2021年6月30日执行经过同行评审的检索策略,然后分别于2021年7月30日和2021年9月15日前完成标题和摘要以及全文文章的评审。我们将于2021年11月15日前完成全文研究数据提取和偏倚风险评估。我们预计能够在2022年1月30日前提交稿件进行同行评审。
本研究将识别、综合并确定与外周动脉疾病患者下肢血管重建手术后早期和延迟SSI风险因素相关的累积证据的确定性。研究结果将用于指导实践、临床实践声明和指南以及后续研究。
国际前瞻性系统评价注册库(PROSPERO)CRD42021242557;https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=242557。
国际注册报告识别号(IRRID):PRR1-10.2196/28759。